InfoWorld

AI-assisted software development with Amazon Q Developer

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...
GEN

Recursion, Roche Unveil Microglia Map of Neuro Disease Targets

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
The Chronicle of Higher Education

Students Are Using ChatGPT to Write Their Personal Essays Now

I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...
ZDNet

People are using ChatGPT to write their text messages - here's how you can tell

People are using AI to write sensitive messages to loved ones. Detecting AI-generated text is becoming more difficult as chatbots evolve. Some tech leaders have promoted this use of AI in their ...
CNN

They’re using the techniques honed by oil and gas to find near-limitless clean energy beneath our feet

Deep beneath Utah’s desert soil, an oil drill bored through the Earth at a blistering pace earlier this spring. Gnarly looking drill bits tore through granite at around 300 feet per hour. It was done ...
Newsweek

Number of Students Using AI for Schoolwork Surges by Double-Digits

The adoption of artificial intelligence (AI) in U.S. classrooms has accelerated rapidly over the past year, with double-digit growth in the number of students using AI tools for schoolwork, according ...
The New York Times

I Teach Creative Writing. This Is What A.I. Is Doing to Students.

Ms. O’Rourke is the executive editor of The Yale Review and a professor of creative writing at Yale University. July 18, 2025 When I first told ChatGPT who I was, it sent a gushing reply: “Oh wow — it ...
The New Yorker

Can A.I. Find Cures for Untreatable Diseases—Using Drugs We Already Have?

For this week’s Open Questions column, Dhruv Khullar is filling in for Joshua Rothman. When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started ...
Seeking Alpha

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio ...
Nasdaq

Recursion Acquires Full Ownership of ENPP1 Inhibitor Program REV102 from Rallybio for Hypophosphatasia Treatment

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...
Nasdaq

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...